← CLOVER HEALTH INVESTMENTS, CORP. /DE
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | — | $92.3m | $300.0m | $103.8m | $122.9m | $194.5m | $78.3m | |
| Short-term investments | — | $4.1m | $293.9m | $41.5m | $12.2m | $0 | $17.0m | |
| Healthcare receivables | — | $38.7m | $48.0m | $70.6m | $64.2m | $51.5m | $94.9m | |
| Prepaid expenses | — | $7.8m | $9.4m | $18.1m | $14.4m | $13.2m | $18.2m | |
| Total current assets | $0 | $28.3m | $752.5m | $625.0m | $428.0m | $343.1m | $307.9m | |
| Property and equipment, net | — | $2.1m | $2.3m | $5.8m | $5.1m | $5.3m | $6.4m | |
| Other intangible assets | — | $4.2m | $4.2m | $20.0m | $3.0m | $3.0m | $3.0m | |
| Investment securities, available-for-sale (Amortized cost: 2025: $23,231; 2024: $27,153) | — | $0 | $21.1m | $137.4m | $120.2m | $201.7m | $187.1m | |
| Investment securities, held-to-maturity (Fair value: 2025: $1,779; 2024: $15) | — | $429k | $335k | $742k | $793k | $14.3m | $12.6m | |
| Other assets, current | — | $299k | $18.0m | $4.0m | $1.4m | $15.6m | $10.6m | |
| Other assets, non-current | — | $8.9m | $10.4m | $15.7m | $10.2m | $13.3m | $24.1m | |
| Unpaid claims | — | $102.4m | $138.6m | $141.9m | $138.6m | $156.4m | $153.2m | |
| Other liabilities, current | — | $5k | $73k | $486k | $2.4m | $3.5m | $3.3m | |
| Other liabilities, non-current | — | $13.1m | $14.1m | $16.2m | $20.2m | $26.1m | $23.5m | |
| Total assets | $100k | $856.4m | $950.8m | $808.6m | $570.7m | $580.7m | $541.0m | |
| Total liabilities and stockholders' equity | $100k | $856.4m | $950.8m | $808.6m | $570.7m | $580.7m | $541.0m | |
| Accrued retrospective premiums | — | $34.8m | $34.9m | $20.4m | $22.1m | $41.3m | $63.9m | |
| Accounts payable and accrued expenses | — | $30.7m | $28.1m | $32.4m | $37.2m | $34.6m | $36.2m | |
| Accrued salaries and benefits | — | $4.0m | $15.1m | $24.0m | $21.1m | $19.1m | $16.0m | |
| Total current liabilities | $118k | $33.9m | $372.6m | $440.7m | $261.1m | $213.5m | $208.8m | |
| Total liabilities | $118k | $62.9m | $411.5m | $460.9m | $284.3m | $239.6m | $232.3m | |
| Common stock, value | $0 | $2k | $46k | $46k | $49k | $50k | $52k | |
| Additional paid-in capital | $0 | $11.8m | $2.2b | $2.3b | $2.5b | $2.6b | $2.7b | |
| Accumulated other comprehensive income (loss) | — | $10k | ($1.9m) | ($9.4m) | ($2.4m) | ($1.6m) | $528k | |
| Accumulated deficit | ($18k) | ($6.8m) | ($1.6b) | ($2.0b) | ($2.2b) | ($2.2b) | ($2.3b) | |
| Less: Treasury stock, at cost; 33,412,273 and 18,752,947 shares held at December 31, 2025 and December 31, 2024, respectively | — | — | ($147k) | ($6.5m) | ($12.7m) | ($31.0m) | ($86.2m) | |
| Total stockholders' equity | — | ($613.2m) | $539.3m | $347.7m | $286.4m | $341.1m | $308.7m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.